44 related articles for article (PubMed ID: 1355678)
1. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes.
Hayashi S; Watanabe J; Kawajiri K
Jpn J Cancer Res; 1992 Aug; 83(8):866-70. PubMed ID: 1399823
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of CYP2D6 locus in the Korean population: identification of rare poor metabolizer alleles at the nucleotide level.
Ryu SW; Kim YJ; Kim E
Mol Cells; 1998 Dec; 8(6):758-63. PubMed ID: 9895131
[TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphisms of Glutathione-Related Enzymes (GSTM1, GSTT1, and GSTP1) and Schizophrenia Risk: A Meta-Analysis.
Kim SK; Kang SW; Chung JH; Park HJ; Cho KB; Park MS
Int J Mol Sci; 2015 Aug; 16(8):19602-11. PubMed ID: 26295386
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.
Kiyohara C; Shirakawa T; Hopkin JM
Environ Health Prev Med; 2002 May; 7(2):47-59. PubMed ID: 21432264
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
Zanger UM; Raimundo S; Eichelbaum M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
[TBL] [Abstract][Full Text] [Related]
6. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.
Christensen PM; Gøtzsche PC; Brøsen K
Eur J Clin Pharmacol; 1997; 51(5):389-93. PubMed ID: 9049580
[TBL] [Abstract][Full Text] [Related]
7. Assessment of liver metabolic function. Clinical implications.
Brockmöller J; Roots I
Clin Pharmacokinet; 1994 Sep; 27(3):216-48. PubMed ID: 7988103
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region.
Drakoulis N; Cascorbi I; Brockmöller J; Gross CR; Roots I
Clin Investig; 1994 Feb; 72(3):240-8. PubMed ID: 7912124
[TBL] [Abstract][Full Text] [Related]
9. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
10. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
11. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
Roots I; Brockmöller J; Drakoulis N; Loddenkemper R
Clin Investig; 1992; 70(3-4):307-19. PubMed ID: 1355678
[TBL] [Abstract][Full Text] [Related]
12. PCR-based CYP2D6 genotyping for Finnish lung cancer patients.
Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Pelkonen O; Vainio H
Pharmacogenetics; 1993 Feb; 3(1):19-27. PubMed ID: 8097947
[TBL] [Abstract][Full Text] [Related]
13. Detection of DNA sequence polymorphisms in carcinogen metabolism genes by polymerase chain reaction.
Bell DA
Environ Mol Mutagen; 1991; 18(4):245-8. PubMed ID: 1684153
[TBL] [Abstract][Full Text] [Related]
14. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
[TBL] [Abstract][Full Text] [Related]
15. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer.
Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Sorsa M; Vainio H
Pharmacogenetics; 1992 Dec; 2(6):259-63. PubMed ID: 1306126
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
